MICHELLE EMMONS: Open Payments
NPI 1144775131 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,795 in 93 payments from 20 companies in 2025. Trend: 2023 $321 · 2024 $407 · 2025 $1,795
Food & beverage: $1,795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $379 |
| Eisai Inc. | 9 | $239 |
| PFIZER INC. | 14 | $189 |
| Biogen, Inc. | 7 | $161 |
| UCB, Inc. | 11 | $157 |
| Lundbeck LLC | 5 | $118 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| Janssen Biotech, Inc. | 3 | $82 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $53 |
Products named: LEQEMBI, NURTEC ODT, BOTOX, UBRELVY, Symbravo, Briviact, VYEPTI, KISUNLA.
Industry payments across AL — which companies pay providers there.
